1 / 13

Atopic Dermatitis Drugs Market Trends, Share, Size, Analysis 2019-2027

The Global Atopic Dermatitis Drugs Market Should Grow With a CAGR of 4.77% Over the Forecast Period. The Base Year Considered for the Study Is 2017 and the Forecast Period Is 2019-2027.

inkwoodresearch
Télécharger la présentation

Atopic Dermatitis Drugs Market Trends, Share, Size, Analysis 2019-2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ATOPIC DERMATITIS DRUGS Forecast2019-2027

  2. According to market expectations, the global atopic dermatitis drugs market should grow with a CAGR of 4.77% over the forecast period. The base year considered for the study is 2017 and the forecast period is 2019-2027. • The global atopic dermatitis drugs market is primarily driven by factors such as the increasing prevalence of food allergies causing atopic dermatitis, the rising focus on systematic therapies and the ever increasing use of pharmacological products in developing countries

  3. The important driver increasing growth in the global atopic dermatitis drugs market is the high prevalence of food allergies exacerbating atopic dermatitis. • It is estimated that food allergy and severe atopic dermatitis coexist in about one-third of all children with atopic dermatitis. • The atopic dermatitis drugs market is broadly classified into two segments on the basis of drug classes and the route of administration.

  4. “Global atopic dermatitis drugs market should grow with a CAGR of 4.77% over the forecast period. The base year considered for the study is 2017 and the forecast period is 2019-2027”

  5. The North American market for atopic dermatitis drugs is the largest in the world with an expected CAGR of 4.17% for the forecast period of 2019-2027.

  6. Experts have estimated that a high number of people belonging to the European population suffer from conditions such as conjunctivitis, skin allergies and food allergies. The market for atopic dermatitis drugs in Europe is, therefore expected to showcase a CAGR of 3.30% over the forecast period of 2019-2027.

  7. According to market forecasts for 2019-2027, the Asia Pacific market for atopic dermatitis drugs seems to be growing at a faster rate than all other regional markets with a CAGR of 7.57%. The main reason for this may be the lack of proper hygiene and the prevalence of allergic conditions in the population of this area.

  8. Leading players in the global atopic dermatitis drug market are Allergan Plc, Aqua Pharmaceuticals (An Almirall Company), Astellas Pharma Inc., Bayer Ag, BiofronteraAg,Bristol-Myers Squibb,Stiefel Laboratories Inc, Encore Dermatology, Galderma Sa, Leo Pharma, Meda Pharmaceuticals (Mylan N.V.),Novartis Ag, Pfizer, Regeneron Pharmaceuticals, Sanofi Sa, Valent Pharmaceutical Inc. and several others.

More Related